Found: 38
Select item for more details and to access through your institution.
B cell receptor dependent enhancement of dengue virus infection.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 10, p. 1, doi. 10.1371/journal.ppat.1012683
- By:
- Publication type:
- Article
Coronavirus Antibody Responses before COVID-19 Pandemic, Africa and Thailand.
- Published in:
- Emerging Infectious Diseases, 2022, v. 28, n. 11, p. 2214, doi. 10.3201/eid2811.221041
- By:
- Publication type:
- Article
Monomeric IgA Antagonizes IgG-Mediated Enhancement of DENV Infection.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.777672
- By:
- Publication type:
- Article
Preparation of Clinical-Grade Recombinant Canarypox--Human Immunodeficiency Virus Vaccine--Loaded Human Dendritic Cells.
- Published in:
- Journal of Infectious Diseases, 2002, v. 186, n. 9, p. 1242, doi. 10.1086/344302
- By:
- Publication type:
- Article
Identification of Immunodominant CD4-Restricted Epitopes Co-Located with Antibody Binding Sites in Individuals Vaccinated with ALVAC-HIV and AIDSVAX B/E.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0115582
- By:
- Publication type:
- Article
Heterologous Prime-Boost Regimens Using rAd35 and rMVA Vectors Elicit Stronger Cellular Immune Responses to HIV Proteins Than Homologous Regimens.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0045840
- By:
- Publication type:
- Article
HIV-1 Envelope Resistance to Proteasomal Cleavage: Implications for Vaccine Induced Immune Responses.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0042579
- By:
- Publication type:
- Article
A Double-Blind Randomized Phase I Clinical Trial Targeting ALVAC-HIV Vaccine to Human Dendritic Cells.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0024254
- By:
- Publication type:
- Article
Innate and Adaptive Immune Responses Both Contribute to Pathological CD4 T Cell Activation in HIV-1 Infected Ugandans.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0018779
- By:
- Publication type:
- Article
Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate.
- Published in:
- PLoS ONE, 2010, v. 5, n. 11, p. 1, doi. 10.1371/journal.pone.0013983
- By:
- Publication type:
- Article
High-Throughput High-Resolution Class I HLA Genotyping in East Africa.
- Published in:
- PLoS ONE, 2010, v. 5, n. 5, p. 1, doi. 10.1371/journal.pone.0010751
- By:
- Publication type:
- Article
Dynamics of Dengue Virus (DENV)-Specific B Cells in the Response to DENV Serotype 1 Infections, Using Flow Cytometry With Labeled Virions.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Temporally integrated single cell RNA sequencing analysis of PBMC from experimental and natural primary human DENV-1 infections.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 1, p. 1, doi. 10.1371/journal.ppat.1009240
- By:
- Publication type:
- Article
Assessing the Diversity and Stability of Cellular Immunity Generated in Response to the Candidate Live-Attenuated Dengue Virus Vaccine TAK-003.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01778
- By:
- Publication type:
- Article
Longitudinal Analysis of Memory B and T Cell Responses to Dengue Virus in a 5-Year Prospective Cohort Study in Thailand.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01359
- By:
- Publication type:
- Article
Dissecting the heterogeneity of DENV vaccine-elicited cellular immunity using single-cell RNA sequencing and metabolic profiling.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-11634-7
- By:
- Publication type:
- Article
OMIP-007: Phenotypic analysis of human natural killer cells.
- Published in:
- Cytometry. Part A, 2012, v. 81A, n. 6, p. 447, doi. 10.1002/cyto.a.22033
- By:
- Publication type:
- Article
Protective versus pathologic pre-exposure cytokine profiles in dengue virus infection.
- Published in:
- PLoS Neglected Tropical Diseases, 2018, v. 12, n. 12, p. 1, doi. 10.1371/journal.pntd.0006975
- By:
- Publication type:
- Article
Long term T cell response and safety of a tetravalent dengue vaccine in healthy children.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00967-0
- By:
- Publication type:
- Article
Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00537-2
- By:
- Publication type:
- Article
Analysis of cell-associated DENV RNA by oligo(dT) primed 5' capture scRNAseq.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-65939-5
- By:
- Publication type:
- Article
Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques.
- Published in:
- PLoS Neglected Tropical Diseases, 2020, v. 14, n. 4, p. 1, doi. 10.1371/journal.pntd.0008191
- By:
- Publication type:
- Article
Stochastic Model of the Adaptive Immune Response Predicts Disease Severity and Captures Enhanced Cross-Reactivity in Natural Dengue Infections.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.696755
- By:
- Publication type:
- Article
Longitudinal Analysis of Dengue Virus–Specific Memory T Cell Responses and Their Association With Clinical Outcome in Subsequent DENV Infection.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.710300
- By:
- Publication type:
- Article
Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 5, p. 916, doi. 10.3390/v13050916
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Dengue Virus Serotype-1 Purified-inactivated Vaccine: Results of a Phase 1 Clinical Trial.
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2015, v. 93, n. 3, p. 454, doi. 10.4269/ajtmh.14-0819
- By:
- Publication type:
- Article
Defining epitope coverage requirements for T cell-based HIV vaccines: theoretical considerations and practical applications.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques.
- Published in:
- PLoS Pathogens, 2017, v. 13, n. 8, p. 1, doi. 10.1371/journal.ppat.1006487
- By:
- Publication type:
- Article
SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00414-4
- By:
- Publication type:
- Article
Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00339-y
- By:
- Publication type:
- Article
Transcriptomic signatures of NK cells suggest impaired responsiveness in HIV-1 infection and increased activity post-vaccination.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-03618-w
- By:
- Publication type:
- Article
Non‐structural protein 1‐specific antibodies directed against Zika virus in humans mediate antibody‐dependent cellular cytotoxicity.
- Published in:
- Immunology, 2021, v. 164, n. 2, p. 386, doi. 10.1111/imm.13380
- By:
- Publication type:
- Article
Evolution of inflammation and immunity in a dengue virus 1 human infection model.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 668, p. 1, doi. 10.1126/scitranslmed.abo5019
- By:
- Publication type:
- Article
Soluble NS1 Antagonizes IgG- and IgA- Mediated Monocytic Phagocytosis of DENV Infected Cells.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 1, p. 70, doi. 10.1093/infdis/jiad122
- By:
- Publication type:
- Article
Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase 1 Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Phase 1, Open-Label Assessment of a Dengue Virus-1 Live Virus Human Challenge Strain.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Effects of Japanese Encephalitis Vaccine and Accelerated Dosing Scheduling on the Immunogenicity of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine: A Phase II, Randomized, Open-Label, Single-Center Trial in Adults Aged 18 to 45 Years in the United States
- Published in:
- Journal of Infectious Diseases, 2020, v. 221, n. 7, p. 1057, doi. 10.1093/infdis/jiz592
- By:
- Publication type:
- Article
The Effects of Japanese Encephalitis Vaccine and Accelerated Dosing Scheduling on the Immunogenicity of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine: A Phase II, Randomized, Open-Label, Single-Center Trial in Adults Aged 18 to 45 Years in the United States.
- Published in:
- 2020
- By:
- Publication type:
- journal article